Skip NavigationSkip to Content

HIV integrase inhibitors with nucleobase scaffolds: Discovery of a highly potent anti-HIV agent

  1. Author:
    Nair, V.
    Chi, G.
    Ptak, R.
    Neamati, N.
  2. Author Address

    Univ Georgia, Ctr Drug Discovery, Athens, GA 30602 USA. Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA. So Res Inst, Infect Dis Res Dept, Frederick, MD 21701 USA. Univ So Calif, Dept Pharmaceut Sci, Los Angeles, CA 90089 USA.;Nair, V, Univ Georgia, Ctr Drug Discovery, Athens, GA 30602 USA.;vnair@rx.uga.edu
    1. Year: 2006
    2. Date: Jan
  1. Journal: Journal of Medicinal Chemistry
    1. 49
    2. 2
    3. Pages: 445-447
  2. Type of Article: Article
  3. ISSN: 0022-2623
  1. Abstract:

    HIV integrase is essential for HIV replication. However, there are currently no integrase inhibitors in clinical use for AIDS. We have discovered a conceptually new beta-diketo acid that is a powerful inhibitor of both the 3'-processing and strand transfer steps of HIV-1 integrase. The in vitro anti-HIV data of this inhibitor were remarkable as exemplified by its highly potent antiviral therapeutic efficacy against HIVTEKI and HIV-1(NL4-3) replication in PBMC (TI > 4,000 and > 10,000, respectively).

    See More

External Sources

  1. DOI: 10.1021/jm0508890
  2. WOS: 000234836200002

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel